These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29188853)

  • 21. Comparison of PC and iPad administrations of the Cogstate Brief Battery in the Mayo Clinic Study of Aging: Assessing cross-modality equivalence of computerized neuropsychological tests.
    Stricker NH; Lundt ES; Edwards KK; Machulda MM; Kremers WK; Roberts RO; Knopman DS; Petersen RC; Mielke MM
    Clin Neuropsychol; 2019 Aug; 33(6):1102-1126. PubMed ID: 30417735
    [No Abstract]   [Full Text] [Related]  

  • 22. A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
    Pudumjee SB; Lundt ES; Albertson SM; Machulda MM; Kremers WK; Jack CR; Knopman DS; Petersen RC; Mielke MM; Stricker NH
    J Alzheimers Dis; 2021; 83(2):861-877. PubMed ID: 34366338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the NIH Toolbox-Cognition Battery against legacy neurocognitive measures in adults with cognitive impairments: An exploratory analysis.
    Kringle EA; Novelli EM; Butters MA; Skidmore ER
    J Int Neuropsychol Soc; 2023 Jun; 29(5):472-479. PubMed ID: 36062530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of a brief computerized cognitive screening test in dementia.
    Hammers D; Spurgeon E; Ryan K; Persad C; Barbas N; Heidebrink J; Darby D; Giordani B
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):89-99. PubMed ID: 22689701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.
    Yechoor N; Towe SL; Robertson KR; Westreich D; Nakasujja N; Meade CS
    J Neurovirol; 2016 Dec; 22(6):808-815. PubMed ID: 27245592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
    Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
    JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures.
    Davis MT; DellaGioia N; Matuskey D; Harel B; Maruff P; Pietrzak RH; Esterlis I
    J Affect Disord; 2017 Aug; 218():82-85. PubMed ID: 28460315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research.
    McKay NS; Millar PR; Nicosia J; Aschenbrenner AJ; Gordon BA; Benzinger TLS; Cruchaga CC; Schindler SE; Morris JC; Hassenstab J
    Neuropsychology; 2024 Jul; 38(5):443-464. PubMed ID: 38602816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Chinese version of the CogState computerised cognitive assessment battery in Taiwanese patients with heart failure.
    Chou CC; Pressler SJ; Giordani B; Fetzer SJ
    J Clin Nurs; 2015 Nov; 24(21-22):3147-54. PubMed ID: 26388285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 32. Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma.
    Cerhan JH; Caine C; Anderson SK; Johnson DR; Lachance DH; Yan E; Brown PD
    Neurooncol Pract; 2019 Jan; 6(1):71-77. PubMed ID: 31386012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel measures for Alzheimer's disease prevention trials (NoMAD).
    Bell SA; Cohen HR; Lee S; Kim H; Ciarleglio A; Andrews H; Rivera AM; Igwe K; Brickman AM; Devanand DP; Harvey PD; Schneider LS; Goldberg TE
    Contemp Clin Trials; 2021 Jul; 106():106425. PubMed ID: 33933666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Lim YY; Ellis KA; Harrington K; Ames D; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Darby D; Maruff P; The Aibl Research Group
    J Clin Exp Neuropsychol; 2012; 34(4):345-58. PubMed ID: 22248010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline characterization of the ARMADA (Assessing Reliable Measurement in Alzheimer's Disease) study cohorts.
    Karpouzian-Rogers T; Ho E; Novack M; Chinkers M; Bedjeti K; Nowinski C; Giordani B; Gershon R; Weintraub S
    Alzheimers Dement; 2023 May; 19(5):1974-1982. PubMed ID: 36396612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cogstate Brief Battery: Cognition and the feigning of cognitive impairment in chronic pain.
    Lupu T; Braw Y; Sacher Y; Ratmansky M
    Appl Neuropsychol Adult; 2022; 29(6):1332-1343. PubMed ID: 33492175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease.
    Jutten RJ; Rentz DM; Fu JF; Mayblyum DV; Amariglio RE; Buckley RF; Properzi MJ; Maruff P; Stark CE; Yassa MA; Johnson KA; Sperling RA; Papp KV
    Front Aging Neurosci; 2021; 13():800126. PubMed ID: 35095476
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of cognitive functioning as measured by the Ruff Figural Fluency Test and the CogState computerized battery within the LifeLines Cohort Study.
    Kuiper JS; Oude Voshaar RC; Verhoeven FEA; Zuidema SU; Smidt N
    BMC Psychol; 2017 May; 5(1):15. PubMed ID: 28494817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
    Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
    Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of the NIH toolbox cognitive battery in a healthy oldest-old 85+ sample.
    Nolin SA; Cowart H; Merritt S; McInerney K; Bharadwaj PK; Franchetti MK; Raichlen DA; Jessup CJ; Hishaw GA; Van Etten EJ; Trouard TP; Geldmacher DS; Wadley VG; Porges ES; Woods AJ; Cohen RA; Levin BE; Rundek T; Alexander GE; Visscher KM
    J Int Neuropsychol Soc; 2023 Jul; 29(6):605-614. PubMed ID: 36239453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.